Published in Infect Immun on July 30, 2007
Pathogenic neisseriae: surface modulation, pathogenesis and infection control. Nat Rev Microbiol (2009) 1.87
Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines. Infect Immun (2008) 1.66
Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor h-binding protein. Infect Immun (2008) 1.61
Review of meningococcal group B vaccines. Clin Infect Dis (2010) 1.58
Structural basis for iron piracy by pathogenic Neisseria. Nature (2012) 1.50
Meningococcal outer membrane vesicle vaccines derived from mutant strains engineered to express factor H binding proteins from antigenic variant groups 1 and 2. Clin Vaccine Immunol (2008) 1.22
An outer membrane receptor of Neisseria meningitidis involved in zinc acquisition with vaccine potential. PLoS Pathog (2010) 1.19
Bactericidal antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed factor H-binding protein and genetically attenuated endotoxin. J Infect Dis (2008) 1.19
A region of the N-terminal domain of meningococcal factor H-binding protein that elicits bactericidal antibody across antigenic variant groups. Mol Immunol (2009) 1.16
Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and neisserial heparin binding antigen. Vaccine (2011) 1.11
Genetically modified L3,7 and L2 lipooligosaccharides from Neisseria meningitidis serogroup B confer a broad cross-bactericidal response. Infect Immun (2009) 1.07
A critical threshold of meningococcal factor H binding protein expression is required for increased breadth of protective antibodies elicited by native outer membrane vesicle vaccines. Clin Vaccine Immunol (2011) 0.97
Dual pili post-translational modifications synergize to mediate meningococcal adherence to platelet activating factor receptor on human airway cells. PLoS Pathog (2013) 0.95
Meningococcal serogroup B vaccines: will they live up to expectations? Expert Rev Vaccines (2011) 0.92
Vaccine development against Neisseria meningitidis. Microb Biotechnol (2011) 0.87
Phase variation of PorA, a major outer membrane protein, mediates escape of bactericidal antibodies by Neisseria meningitidis. Infect Immun (2013) 0.86
Three doses of an experimental detoxified L3-derived lipooligosaccharide meningococcal vaccine offer good safety but low immunogenicity in healthy young adults. Clin Vaccine Immunol (2010) 0.86
Identification and characterization of gonococcal iron transport systems as potential vaccine antigens. Future Microbiol (2008) 0.85
Loss of outer membrane protein C in Escherichia coli contributes to both antibiotic resistance and escaping antibody-dependent bactericidal activity. Infect Immun (2012) 0.83
Phase variation mediates reductions in expression of surface proteins during persistent meningococcal carriage. Infect Immun (2014) 0.83
Importance of antibodies to lipopolysaccharide in natural and vaccine-induced serum bactericidal activity against Neisseria meningitidis group B. Infect Immun (2011) 0.83
Meningococcal outer membrane protein NhhA triggers apoptosis in macrophages. PLoS One (2012) 0.81
ZnuD, a potential candidate for a simple and universal Neisseria meningitidis vaccine. Infect Immun (2013) 0.81
Characterization of an antibody depletion assay for analysis of bactericidal antibody specificity. Clin Vaccine Immunol (2009) 0.80
The distribution and 'in vivo' phase variation status of haemoglobin receptors in invasive meningococcal serogroup B disease: genotypic and phenotypic analysis. PLoS One (2013) 0.80
A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial. J Infect (2015) 0.80
The meningococcal adhesin NhhA provokes proinflammatory responses in macrophages via toll-like receptor 4-dependent and -independent pathways. Infect Immun (2012) 0.80
Evaluation of truncated NhhA protein as a candidate meningococcal vaccine antigen. PLoS One (2013) 0.80
A naturally occurring single-residue mutation in the translocator domain of Neisseria meningitidis NhhA affects trimerization, surface localization, and adhesive capabilities. Infect Immun (2011) 0.79
The Long Road to an Effective Vaccine for Meningococcus Group B (MenB). Ann Med Surg (Lond) (2013) 0.78
FetA Antibodies Induced by an Outer Membrane Vesicle Vaccine Derived from a Serogroup B Meningococcal Isolate with Constitutive FetA Expression. PLoS One (2015) 0.77
Meningococcal Antigen Typing System Development and Application to the Evaluation of Effectiveness of Meningococcal B Vaccine and Possible Use for Other Purposes. J Immunol Res (2015) 0.76
Identification and therapeutic potential of a vitronectin binding region of meningococcal msf. PLoS One (2015) 0.76
Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev Infect Dis (1985) 6.62
Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet (1983) 5.63
Role of a highly conserved bacterial protein in outer membrane protein assembly. Science (2003) 4.78
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile. JAMA (1999) 3.69
NadA, a novel vaccine candidate of Neisseria meningitidis. J Exp Med (2002) 3.26
The Omp85 family of proteins is essential for outer membrane biogenesis in mitochondria and bacteria. J Cell Biol (2003) 3.11
Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil. Lancet (1992) 2.52
Escherichia coli tol-pal mutants form outer membrane vesicles. J Bacteriol (1998) 2.48
Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine. Infect Immun (1995) 2.44
The classical complement pathway: activation and regulation of the first complement component. Adv Immunol (1985) 2.38
MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain. Vaccine (2005) 2.20
Cloning and characterization of Neisseria meningitidis genes encoding the transferrin-binding proteins Tbp1 and Tbp2. Gene (1993) 2.19
Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease. NIPH Ann (1991) 2.13
Iron acquisition systems in the pathogenic Neisseria. Mol Microbiol (1999) 1.97
Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection. J Exp Med (1997) 1.76
Differences in surface expression of NspA among Neisseria meningitidis group B strains. Infect Immun (1999) 1.76
Transferrin-binding proteins isolated from Neisseria meningitidis elicit protective and bactericidal antibodies in laboratory animals. Vaccine (1993) 1.75
Crystal structure of Neisserial surface protein A (NspA), a conserved outer membrane protein with vaccine potential. J Biol Chem (2003) 1.54
Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993-6. European Meningitis Surveillance Group. Epidemiol Infect (1999) 1.53
Immune responses in humans and animals to meningococcal transferrin-binding proteins: implications for vaccine design. Infect Immun (1994) 1.51
Biogenesis of the Gram-negative bacterial outer membrane. Curr Opin Microbiol (2004) 1.47
Common antigenic domains in transferrin-binding protein 2 of Neisseria meningitidis, Neisseria gonorrhoeae, and Haemophilus influenzae type b. Infect Immun (1992) 1.38
Global epidemiology of meningococcal disease and vaccine efficacy. Pediatr Infect Dis J (2004) 1.33
Sequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strains. Infect Immun (2002) 1.29
Generation of capsule-deficient Neisseria meningitidis strains by homologous recombination. Mol Microbiol (1990) 1.29
Polar localization of the autotransporter family of large bacterial virulence proteins. J Bacteriol (2006) 1.24
Outer membrane protein vesicle vaccines for meningococcal disease. Methods Mol Med (2001) 1.23
Human antibody response to meningococcal transferrin binding proteins: evidence for vaccine potential. Vaccine (1995) 1.21
In vivo expression of Neisseria meningitidis proteins homologous to the Haemophilus influenzae Hap and Hia autotransporters. FEMS Immunol Med Microbiol (2001) 1.13
Identification and characterisation of a novel conserved outer membrane protein from Neisseria meningitidis. FEMS Immunol Med Microbiol (2000) 1.12
Evidence for autoimmune antibodies directed against embryonic neural cell adhesion molecules (N-CAM) in patients with group B meningitis. J Neuroimmunol (1990) 1.12
The RTX cytotoxin-related FrpA protein of Neisseria meningitidis is secreted extracellularly by meningococci and by HlyBD+ Escherichia coli. Infect Immun (1993) 1.11
Tol-Pal proteins are critical cell envelope components of Erwinia chrysanthemi affecting cell morphology and virulence. Microbiology (2005) 1.11
Omp85 proteins of Neisseria gonorrhoeae and Neisseria meningitidis are similar to Haemophilus influenzae D-15-Ag and Pasteurella multocida Oma87. Microb Pathog (1998) 1.02
Towards an improved serogroup B Neisseria meningitidis vaccine. Expert Opin Biol Ther (2005) 1.01
Immunogenicity and structural characterisation of an in vitro folded meningococcal siderophore receptor (FrpB, FetA). Microbes Infect (2006) 1.00
New zealand epidemic strain meningococcal B outer membrane vesicle vaccine in children aged 16-24 months. Pediatr Infect Dis J (2007) 0.94
Evidence of positive Darwinian selection in Omp85, a highly conserved bacterial outer membrane protein essential for cell viability. J Mol Evol (2005) 0.94
Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis. Vaccine (2005) 0.93
Sequence analysis of the structural tbpA gene: protein topology and variable regions within neisserial receptors for transferrin iron acquisition. Microb Pathog (1997) 0.92
A common conserved amino acid motif module shared by bacterial and intercellular adhesins: bacterial adherence mimicking cell cell recognition? Microbiology (2001) 0.86
Alternative vaccine strategies to prevent serogroup B meningococcal diseases. Vaccine (2001) 0.82
Role of a highly conserved bacterial protein in outer membrane protein assembly. Science (2003) 4.78
Biogenesis of the gram-negative bacterial outer membrane. Annu Rev Microbiol (2007) 3.52
Structure of the translocator domain of a bacterial autotransporter. EMBO J (2004) 3.14
Assembly factor Omp85 recognizes its outer membrane protein substrates by a species-specific C-terminal motif. PLoS Biol (2006) 3.12
Identification of an outer membrane protein required for the transport of lipopolysaccharide to the bacterial cell surface. Proc Natl Acad Sci U S A (2004) 2.43
The phasevarion: phase variation of type III DNA methyltransferases controls coordinated switching in multiple genes. Nat Rev Microbiol (2010) 2.25
Analysis of nontypeable haemophilus influenzae phase-variable genes during experimental human nasopharyngeal colonization. J Infect Dis (2013) 1.64
The phasevarion: a genetic system controlling coordinated, random switching of expression of multiple genes. Proc Natl Acad Sci U S A (2005) 1.63
Biogenesis of beta-barrel membrane proteins in bacteria and eukaryotes: evolutionary conservation and divergence. Cell Mol Life Sci (2009) 1.62
Recombinant probiotics for treatment and prevention of enterotoxigenic Escherichia coli diarrhea. Gastroenterology (2005) 1.58
A Neisserial autotransporter NalP modulating the processing of other autotransporters. Mol Microbiol (2003) 1.56
The outer membrane localization of the Neisseria gonorrhoeae MsrA/B is involved in survival against reactive oxygen species. Proc Natl Acad Sci U S A (2002) 1.55
Crystal structure of Neisserial surface protein A (NspA), a conserved outer membrane protein with vaccine potential. J Biol Chem (2003) 1.54
Lipopolysaccharide transport to the bacterial outer membrane in spheroplasts. J Biol Chem (2004) 1.53
Virulence of Streptococcus pneumoniae: PsaA mutants are hypersensitive to oxidative stress. Infect Immun (2002) 1.52
Defenses against oxidative stress in Neisseria gonorrhoeae and Neisseria meningitidis: distinctive systems for different lifestyles. J Infect Dis (2004) 1.51
Phasevarions mediate random switching of gene expression in pathogenic Neisseria. PLoS Pathog (2009) 1.48
Omp85, an evolutionarily conserved bacterial protein involved in outer-membrane-protein assembly. Res Microbiol (2004) 1.47
Description and nomenclature of Neisseria meningitidis capsule locus. Emerg Infect Dis (2013) 1.47
Biogenesis of the Gram-negative bacterial outer membrane. Curr Opin Microbiol (2004) 1.47
Molecular analysis of the psa permease complex of Streptococcus pneumoniae. Mol Microbiol (2004) 1.46
Staphylococcus aureus LukAB cytotoxin kills human neutrophils by targeting the CD11b subunit of the integrin Mac-1. Proc Natl Acad Sci U S A (2013) 1.45
The multicopper oxidase of Pseudomonas aeruginosa is a ferroxidase with a central role in iron acquisition. Mol Microbiol (2002) 1.41
Signals in bacterial beta-barrel proteins are functional in eukaryotic cells for targeting to and assembly in mitochondria. Proc Natl Acad Sci U S A (2009) 1.40
Characterization of the OxyR regulon of Neisseria gonorrhoeae. Mol Microbiol (2006) 1.40
Functioning of outer membrane protein assembly factor Omp85 requires a single POTRA domain. EMBO Rep (2007) 1.39
Defenses against oxidative stress in Neisseria gonorrhoeae: a system tailored for a challenging environment. Microbiol Mol Biol Rev (2006) 1.36
A type IV pilin, PilA, Contributes To Adherence of Burkholderia pseudomallei and virulence in vivo. Infect Immun (2005) 1.34
Interactions between phage-shock proteins in Escherichia coli. J Bacteriol (2003) 1.33
Central role of manganese in regulation of stress responses, physiology, and metabolism in Streptococcus pneumoniae. J Bacteriol (2010) 1.32
Discovery of virulence factors of pathogenic bacteria. Curr Opin Chem Biol (2008) 1.31
The beta-barrel outer membrane protein assembly complex of Neisseria meningitidis. J Bacteriol (2009) 1.30
Viability of a capsule- and lipopolysaccharide-deficient mutant of Neisseria meningitidis. Infect Immun (2005) 1.27
Identification, characterization and immunogenicity of an O-antigen capsular polysaccharide of Francisella tularensis. PLoS One (2010) 1.26
Cellular solid-state nuclear magnetic resonance spectroscopy. Proc Natl Acad Sci U S A (2012) 1.25
Solid-state NMR spectroscopy on cellular preparations enhanced by dynamic nuclear polarization. Angew Chem Int Ed Engl (2012) 1.25
Polar localization of the autotransporter family of large bacterial virulence proteins. J Bacteriol (2006) 1.24
Role of the pilot protein YscW in the biogenesis of the YscC secretin in Yersinia enterocolitica. J Bacteriol (2004) 1.24
Pilin glycosylation in Neisseria meningitidis occurs by a similar pathway to wzy-dependent O-antigen biosynthesis in Escherichia coli. Biochem Biophys Res Commun (2006) 1.22
Dissemination of lipid A deacylases (pagL) among gram-negative bacteria: identification of active-site histidine and serine residues. J Biol Chem (2004) 1.22
Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens. Infect Immun (2010) 1.22
Structure and electrophysiological properties of the YscC secretin from the type III secretion system of Yersinia enterocolitica. J Bacteriol (2004) 1.22
Phase variable restriction-modification systems in Moraxella catarrhalis. FEMS Immunol Med Microbiol (2002) 1.20
Transcriptional regulation, occurrence and putative role of the Pht family of Streptococcus pneumoniae. Microbiology (2010) 1.19
An outer membrane receptor of Neisseria meningitidis involved in zinc acquisition with vaccine potential. PLoS Pathog (2010) 1.19
Protein secretion and secreted proteins in pathogenic Neisseriaceae. FEMS Microbiol Rev (2006) 1.19
The multi-copper-ion oxidase CueO of Salmonella enterica serovar Typhimurium is required for systemic virulence. Infect Immun (2010) 1.17
OxyR acts as a repressor of catalase expression in Neisseria gonorrhoeae. Infect Immun (2003) 1.16
Three homologues, including two membrane-bound proteins, of the disulfide oxidoreductase DsbA in Neisseria meningitidis: effects on bacterial growth and biogenesis of functional type IV pili. J Biol Chem (2004) 1.16
Haemophilus influenzae phasevarions have evolved from type III DNA restriction systems into epigenetic regulators of gene expression. Nucleic Acids Res (2007) 1.16
Crystal structure and catalytic mechanism of the LPS 3-O-deacylase PagL from Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (2006) 1.15
Plasmid-encoded Tet B tetracycline resistance in Haemophilus parasuis. Antimicrob Agents Chemother (2005) 1.14
NmlR of Neisseria gonorrhoeae: a novel redox responsive transcription factor from the MerR family. Mol Microbiol (2005) 1.13
Phasevarion mediated epigenetic gene regulation in Helicobacter pylori. PLoS One (2011) 1.13
An expedient total synthesis of (-)-dactylolide and formal synthesis of (-)-zampanolide. Org Lett (2005) 1.11
Role of Pseudomonas putida tol-oprL gene products in uptake of solutes through the cytoplasmic membrane. J Bacteriol (2003) 1.11
A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae. Vaccine (2011) 1.10
The mitochondrial porin, VDAC, has retained the ability to be assembled in the bacterial outer membrane. Mol Biol Evol (2009) 1.09
A pneumococcal MerR-like regulator and S-nitrosoglutathione reductase are required for systemic virulence. J Infect Dis (2007) 1.08
Autotransporter secretion: varying on a theme. Res Microbiol (2013) 1.07
PerR controls Mn-dependent resistance to oxidative stress in Neisseria gonorrhoeae. Mol Microbiol (2006) 1.07
Metal binding specificity of the MntABC permease of Neisseria gonorrhoeae and its influence on bacterial growth and interaction with cervical epithelial cells. Infect Immun (2008) 1.07
Expression of the lipopolysaccharide-modifying enzymes PagP and PagL modulates the endotoxic activity of Bordetella pertussis. Infect Immun (2006) 1.07
Genetically modified L3,7 and L2 lipooligosaccharides from Neisseria meningitidis serogroup B confer a broad cross-bactericidal response. Infect Immun (2009) 1.07
Pseudomonas evades immune recognition of flagellin in both mammals and plants. PLoS Pathog (2011) 1.06
Differences in macrophage activation by bacterial DNA and CpG-containing oligonucleotides. J Immunol (2005) 1.06
Thioredoxin reductase is essential for protection of Neisseria gonorrhoeae against killing by nitric oxide and for bacterial growth during interaction with cervical epithelial cells. J Infect Dis (2009) 1.06
Facile construction of unmarked deletion mutants in Burkholderia pseudomallei using sacB counter-selection in sucrose-resistant and sucrose-sensitive isolates. J Microbiol Methods (2008) 1.06
Transcriptional profiling identifies the metabolic phenotype of gonococcal biofilms. Infect Immun (2009) 1.06
Investigation of oxidative stress defenses of Neisseria gonorrhoeae by using a human polymorphonuclear leukocyte survival assay. Infect Immun (2005) 1.05
Identification of a novel Gsp-related pathway required for secretion of the manganese-oxidizing factor of Pseudomonas putida strain GB-1. Mol Microbiol (2003) 1.04
Export of the pseudopilin XcpT of the Pseudomonas aeruginosa type II secretion system via the signal recognition particle-Sec pathway. J Bacteriol (2006) 1.04
Role of the periplasmic chaperones Skp, SurA, and DegQ in outer membrane protein biogenesis in Neisseria meningitidis. J Bacteriol (2011) 1.04
Comparison of pathogen DNA isolation methods from large volumes of whole blood to improve molecular diagnosis of bloodstream infections. PLoS One (2013) 1.04
The bacterial gene lfpA influences the potent induction of calcitonin receptor and osteoclast-related genes in Burkholderia pseudomallei-induced TRAP-positive multinucleated giant cells. Cell Microbiol (2006) 1.03
A Sco homologue plays a role in defence against oxidative stress in pathogenic Neisseria. FEBS Lett (2003) 1.03
The Composition and Metabolic Phenotype of Neisseria gonorrhoeae Biofilms. Front Microbiol (2011) 1.02
The Neisseria lipooligosaccharide-specific alpha-2,3-sialyltransferase is a surface-exposed outer membrane protein. Infect Immun (2002) 1.01
Azurin of pathogenic Neisseria spp. is involved in defense against hydrogen peroxide and survival within cervical epithelial cells. Infect Immun (2005) 1.01
Meningococcal surface fibril (Msf) binds to activated vitronectin and inhibits the terminal complement pathway to increase serum resistance. Mol Microbiol (2011) 1.01
Anaerobic metabolism occurs in the substratum of gonococcal biofilms and may be sustained in part by nitric oxide. Infect Immun (2010) 1.01
Phase variable type III restriction-modification systems of host-adapted bacterial pathogens. Mol Microbiol (2007) 1.01
Analysis of the role of pglI in pilin glycosylation of Neisseria meningitidis. FEMS Immunol Med Microbiol (2004) 1.01
Identification and characterization of pptA: a gene involved in the phase-variable expression of phosphorylcholine on pili of Neisseria meningitidis. Infect Immun (2003) 1.00
Immunogenicity and structural characterisation of an in vitro folded meningococcal siderophore receptor (FrpB, FetA). Microbes Infect (2006) 1.00